Immunotoxin Therapy in Treating Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

December 31, 2000

Conditions

Cervical CancerFallopian Tube CancerHead and Neck CancerLung CancerMalignant MesotheliomaOvarian CancerPancreatic CancerPrimary Peritoneal Cavity Cancer

Interventions

BIOLOGICAL

SS1(dsFv)-PE38 immunotoxin

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00006981 - Immunotoxin Therapy in Treating Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter